Surgery, Gastroenterology and Oncology
Vol. 30, No. 2-Supplement, Aug 2025
One-Year Experience with Surgical Site Infection in Nassiryia Teaching Hospital: Pattern and Hospital Readmission Rate: A Prospective Study
Haroon Lazim Thamir, Muhanad A. Alridha, Saadi Kazem Almajed
ORIGINAL PAPER, Aug 2025
Article DOI: 10.21614/sgo-791

Background: Surgical site infection (SSI) remains one of the most common postoperative complications, contributing significantly to patient morbidity, prolonged hospital stay, and healthcare costs. Understanding local SSI patterns is essential for improving surgical outcomes. Purpose: to investigate SSI in Nassiryia teaching hospital in terms of pattern and hospital readmission rate.

Methods: This prospective study included 300 patients who underwent various surgical procedures. Data on demographic characteristics, comorbidities, surgical details, prophylactic antibiotic use, wound classification, and postoperative outcomes were collected. The association between patient/surgical factors and SSI was analyzed using appropriate statistical

methods.

Results: Out of 300 patients, 47(15.67%) developed SSIs. Superficial infections accounted for 59.57%, while 40.43% were deep infections. The highest SSI rates were observed among patients aged 46–65 years and those with diabetes, hypertension, malignancy, or on regular medication (especially antidiabetics). Emergency procedures, contaminated/dirty wounds, and certain types of surgery were significantly associated with higher infection risk. The use of prophylactic antibiotics showed no significant impact on SSI reduction. The hospital readmission rate due to SSI was 1.67%, aligning with international benchmarks.

Conclusion: The study identified multiple modifiable and non-modifiable risk factors associated with SSIs. Targeted infection control strategies, improved antibiotic stewardship, and enhanced postoperative surveillance are essential to reduce the burden of SSIs and associated hospital readmissions.

INTRODUCTION

Healthcare-associated infections (HAI) represent one of the most significant threats to patient health and continue to constitute a substantial challenge for healthcare providers on a global scale (1). Primarily, these infections are attributed to microorganisms exhibiting antimicrobial resistance (2).

Among the various forms of HAI, SSI stands out as one of the most frequently documented types. SSIs may manifest within a timeframe of 30 to 90 days post-surgical intervention and are classified as infections involving incisions, organ spaces, and organs, characterized by exceptionally high rates of morbidity and mortality (3). SSIs rank as the second most prevalent category, following urinary tract infections, with an occurrence rate of 14% to 16% (4). Patients undergoing surgical procedures often present with intricate comorbidities, thereby complicating the management of SSIs and escalating healthcare costs, particularly with the emergence of antimicrobial-resistant pathogens (5,6).

The ramifications of SSIs extend broadly, impacting both patients and healthcare systems, as they are associated with pain, prolonged hospitalizations, and lost productivity. For instance, SSIs can extend the duration of hospital stays by an average of 10 days. Likewise, they contribute to a surge in therapeutic expenses and the overall cost of surgical procedures, increasing by 300% to 400% (7), while also elevating the likelihood of hospital readmissions and compromising health outcomes (8). Nevertheless, due to inadequate infection prevention measures, the incidence of SSI is significantly higher in low- and middle-income countries compared to their high-income counterparts (9).

The risk factors linked to the onset of an SSI are influenced by specific patient characteristics and clinical conditions, in addition to the nature of the surgical intervention performed (10). Despite the extensive body of clinical research highlighting these risk factors for SSIs following abdominal surgeries, it remains challenging to maintain meticulous detail and to adequately adjust for all variables when estimating specific risk factors (11). A thorough and nuanced evaluation of the multifactorial nature of these risk factors may facilitate enhancements in the quality of surgical care.

Factors that precipitate the occurrence of SSIs are determined by patient-dependent variables (such as age, body mass index, malnutrition, smoking, etc.), surgical parameters (including surgical site, technique, duration, and contamination level of the wound), and environmental influences (12).

The present study aimed to investigate SSI in Nassiryia teaching hospital in terms of pattern and hospital readmission rate.

METHOD

Study Population

This is a prospective study including a total of 300 patients undergoing different surgeries at surgical wards or emergency department at Nassiryia Teaching Hospital ulcer during the period 1st January 2024 to 31st December 2024. The study population for the current study was all adult patients (age ? 18 years) who underwent either elective or emergency surgical procedures at general surgery and gynecology/obstetric wards. Patients who had initial diagnosis of SSIs and underwent surgery involving permanent implants or those with psychiatric chief complaint were excluded from the study. The study was approved by Iraqi Council for Medical Specializations.

Data Collection

Collected information included: demographic data: age, sex, past medical history and drug history. Clinical data: prophylactic antibiotic, type of surgery, drain use, ward, class of wound and SSI. Incidence of SSI was based on culture positive results and/or physician diagnosis.

Follow up

All patients were evaluated and followed up for 30 days postoperatively starting from the date of operation to determine the incidence of SSI.

Statistical Analysis

All data were analyzed with statistical package for social sciences (SPSS) software (version 26). Descriptive statistics were used to present the data. Continuous variables are presented as mean± SD, and categorical variables were presented as frequencies and percentages. Categorical variables were expressed as number and percentage and analyzed with Chi-square test. A value of P < 0.05 was considered statistically significant.

RESULTS

Demographic Characteristics of the Patients

The demographic characteristics of the 300 patients who underwent various surgical procedures reveal a wide age distribution, with a mean age of 35.19±15.63 years, ranging from 5 to 80 years. Most patients (43.7%) were aged between 26 and 45 years. Females constituted the majority of the cohort, accounting for 68%, whereas males made up 32%. Regarding past medical history, 87.7% of the patients had no recorded comorbidities. In terms of drug history, 88.3% of patients reported no regular medication use. Among those on treatment, 6% were receiving antidiabetic drugs, 5.3% were on anti-hypertensive and 0.3% had a history of chemotherapy (table 1).

Table 1- Demographic characteristics of the patients (n=300)

Table 1- Demographic characteristics of the patients (n=300)

Clinical Characteristics of the Patients

The vast majority (92.3%) received prophylactic antibiotics. Laparoscopic cholecystectomy was the most commonly performed surgery (21.3%). Surgical drains were used in 44.3% of cases. Elective surgeries made up the majority at 85%. Regarding wound classification, 48% of wounds were clean, 45.7% were clean-contaminated, and smaller proportions were contaminated (3.3%) or dirty (3%) as shown in table 2. There was no colorectal surgery reported in this study.






Table 2 - Clinical characteristics of the patients (n=300)

Table 2 - Clinical characteristics of the patients (n=300)

Incidence of SSI

Out of a total of 300 patients, SSI occurred in 47 patients, representing an incidence rate of 15.67%, whereas the remaining 253 patients (84.33%) did not develop SSI (fig. 1).

Figure 1 - Incidence of SSI among patients admitted to general surgery ward.

Figure 1 - Incidence of SSI among patients admitted to general surgery ward.

Association of Demographic Factors with SSI

Analysis of demographic characteristics showed a statistically significant association between age and the incidence of SSI (p=0.004). Past medical history showed a highly significant association with SSI development (p<0.001). Among those with SSI, 31.91% had DM, 8.51% had hypertension, and 4.26% had malignancy, compared to much lower rates among patients without SSI. Similarly, drug history was significantly associated with infection (p<0.001); 34.04% of patients with SSI were on antidiabetic medications and 8.51% on anti-hypertensive, while the majority of those without SSI (94.47%) had no history of drug use (table 3).

Table 3 - Association of demographic characteristics with SS

Table 3 - Association of demographic characteristics with SS

Association of Clinical Factors with SSI

Type of surgery showed a highly significant association (p<0.001), with appendectomy (27.66%) and procedures categorized as "others" (36.17%) contributing most frequently to SSIs. The urgency of surgery showed a significant correlation (p=0.002), with emergency procedures associated with a higher SSI rate (29.79%) compared to elective surgeries (12.25%). Wound classification was strongly associated with SSI development (p<0.001); clean wounds accounted for only 29.79% of SSIs, while contaminated and dirty wounds comprised a disproportionately higher percentage (14.89% each) as shown in table 4.

Table 4 - Association of clinical factors with SSI

Table 4 - Association of clinical factors with SSI

Type of SSI

SSI 47 patients. Of those, 28 patients (59.57%) had superficial infections while 19 patients (40.34%) had deep infections (fig. 2).

Figure 2 -3

Hospital readmission

Out of 300 included patients, only 5 patients (1.67%) required hospital readmission due to complications in surgical wounds (fig. 3). Those patients were treated with high doses of antibiotic and discharged well.

DISCUSSION

The present study aimed to investigate SSI in Nassiryia teaching hospital in terms of pattern and hospital readmission rate. According to the result of the study, the incidence rate of SSI was 15.67%. This rate lies with the global incidence. Several studies worldwide indicated that SSI ranges from 11.76% to 35.5% (13-16). In a Turkish study including 422 consecutive patients who underwent emergency and elective surgeries, Duran et al. (17) reported an incidence rate of 15.16% of SSI. In Ethiopia, Misha et al. (14) included a total of 251 patients who were followed up for about two years. Over this follow up period about 53 patients were develop SSI.

This difference in the incidence could be ascribed to many factors before, during, and after surgery, like improper operation theater sterilization, surgical techniques, skin preparation, post-surgical follow up period, the method of wound closure, and antibiotic prophylaxis after certain types of surgery.

In the present study, age was statistically associated with incidence of SSI with the highest age at risk between 46 and 65-year, whereas no sex difference was demonstrated. Past medical history showed a highly significant association with SSI development particularly with DM and those on antidiabetic, anti-hypertensive and chemotherapy medications showed greater incidence of SSI.

Several publications have linked older age to SSI occurrence (18,19). and they explained that by factors indirectly related to age such as increased prevalence of comorbid conditions and a decreased host response to bacterial invasion in older patients. However, this result should be interpreted with caution as it is unlikely that older age has a direct and independent relationship due to the number of confounding factors associated with the ageing process that might lead to poorer wound healing. In a study including 144,485 surgical patients, Kaye et al. (20) found that increasing age independently predicted an increased SSI risk until the age of 65 years, but for ages above 65 years a further increase in age was associated with a decreased SSI risk. The authors speculated that this may be related to a surgical selection bias or a ‘hardy survivor’ effect. This effect describes the tendency that people who survive to an older age may have a genetic composition that enables them to better mitigate health threats compared with the general population (21).

In contrast to the present study, two studies identified male sex as an independent risk factor for development of SSI in the multivariate model (22-24). It was assumed that androgens have a proinflammatory effect on wounds, which impairs re-epithelialization process, whereas in women, estrogens have been shown to have an anti-inflammatory effect, which could account for the difference (25).

Most previous studies emphasized the role of DM in increasing the incidence of SSI (16,25). Hyperglycemia, a hallmark of diabetes, is linked with vascular stiffness, decelerated circulation, microvascular dysfunction, diminished tissue oxygenation, and reduced leukocyte migration to the wound site, thereby predisposing diabetic wounds to infections (26).

Furthermore, the role of inflammatory mediators in inducing insulin resistance and fostering hyperglycemia is noteworthy, as these mediators contribute to immune cell dysfunction through mitochondrial damage (27).

The association between chemotherapy and SSI remains controversial. It was reported that chemo-therapy not only inhibits cell metabolism, rapid cell division, and angiogenesis but also delays wound healing and compromises the patient's immune function (28). In contrast, some authors have shown no significant association between chemotherapy and an increased risk of SSI (29).

This discrepancy between different studies could be attributed to several factors the most important of which are variation in underlying cancer, duration and type of chemotherapy and demographic characteristics of the patients (30).

In the present study, prophylactic antibiotic use was not significantly associated with a reduction in SSIs. This finding is consistent with the results of several meta-analyses and systematic reviews, which have reported no significant benefit of antibiotic prophylaxis in preventing SSIs across various surgical settings (31,32).

However, contrasting evidence exists in the literature. Some systematic reviews and meta-analyses have demonstrated a beneficial effect of prophylactic antibiotics compared to placebo, particularly in the context of elective clean and clean/contaminated plastic surgeries (21,33). These discrepancies may reflect differences in surgical types, patient populations, timing and choice of antibiotics, and institutional infection control practices.

The findings of the present study thus contribute to the ongoing debate regarding the efficacy of antibiotic prophylaxis and underscore the need for procedure-specific guidelines that consider both the benefits and potential drawbacks of routine antibiotic use.

Regarding type of operation, the present study showed that patients underwent appendectomy was more prone to SSI compared to other types of surgical procedures and those with emergency procedures have higher SSI rate compared to elective surgeries. Literatures stated that the rates of SSI are much higher with abdominal surgery than with other types of surgery (34). In addition, appendectomy is regarded as an emergency procedure and such operations often can introduce bacteria into the surgical site or create a more contaminated environment. Furthermore, emergency cases may experience delays in administering prophylactic antibiotics, increasing the risk of infection,. Additionally, emergency surgeries may involve longer operative times, potentially increasing the duration of exposure to bacteria and the risk of SSI (35).

In contrast, elective surgeries allow for careful planning and preparation, including proper sterilization, antibiotic prophylaxis, and wound classification, elective surgeries are typically performed in a controlled environment with minimal risk of contamination, wounds in elective surgeries are more likely to be classified as clean or clean-contaminated, reducing the risk of SSI, and finally elective surgeries often involve prophylactic antibiotic administration, minimizing the risk of infection (36).

In the present study, the association between the type of surgical wound and the incidence of SSIs was direct: the more contaminated the wound class, the elevated the risk of infection. Numerous studies have shown that the "dirty" or "infected" wound class is a major risk factor for SSIs when compared to other wound classes. This is to be expected, as a higher bacterial load increases the likelihood of developing an SSI (37).

In the present study, superficial SSIs accounted for 59.57%, while deep SSIs comprised 40.34% of the total cases. These results are consistent with a study conducted in Ethiopia involving 357 surgical procedures, where superficial SSIs constituted 58% and deep SSIs 42% of cases (38). This similarity may reflect comparable surgical practices, infection control measures, or patient risk profiles in similar resource-limited settings.

However, the current findings contradict those of an Italian study, which reported a lower proportion of superficial SSIs (26.8%) and a higher proportion of deep SSIs (48.8%) (39). The discrepancy could be attributed to differences in healthcare infrastructure, diagnostic criteria, types of surgeries performed, or postoperative surveillance systems. In high-income settings like Italy, more rigorous diagnostic protocols may lead to a higher detection rate of deep infections, or the surgical case mix may involve more procedures with higher inherent risks for deep infections.

In the present study, the hospital readmission rate due SSI was 1.67%, which falls within the range of rates reported globally. For instance, a large-scale study from the United States involving 59,088 patients across 525 hospitals reported readmission rates for SSIs ranging from 1.45% to 6.34% (40). This suggests that the readmission rate observed in the current study aligns with international standards, particularly at the lower end of the spectrum.

Furthermore, an Italian study documented a readmission rate of 3.8% among their patients with SSIs, which is notably higher than the rate found in the current study. This variation may be influenced by differences in healthcare systems, patient follow-up protocols, infection surveillance practices, and the complexity of surgical procedures undertaken in different settings (39).

CONCLUSION

SSIs occurred in 15.67% of patients undergoing surgery, with a superficial infection being the most common type. The readmission rate due to SSI-related complications is relatively low, aligning with international reports. Middle aged patients with comorbid conditions, and individuals on antidiabetic or anti-hypertensive medications are more likely to develop SSIs. Type of surgery, wound class, and urgency of the procedure are significantly linked to infection risk.

Limitations

This study may be limited by its observational nature. Data on SSI may have been underreported, particularly in cases of delayed presentation or treatment at outside facilities. The reliance on medical records and documentation for comorbidities and medication use may introduce reporting or classification bias. Additionally, potential confounders such as perioperative antibiotic use, surgical technique, and intraoperative contamination were not fully controlled. Variability in postoperative follow-up duration could also influence the detection rate of SSIs.

Conflicts of Interest

The authors declare no conflict of interest regarding this article.

Funding

None.

REFERENCES

1. World Health Organization. Report on the Burden of Endemic Health Care-associated Infection Worldwide. World Health Organization; 2011. (accessed January 10, 2021). http://apps. who.int/iris/bitstream/10665/80135/1/9789241501507_eng. Pdf

2. World Health Organization. Global Guidelines on the Prevention of Surgical Site Infection; 2016. (accessed January 12, 2021). https://www.google.com/url?sa=i&rct=j&q=&e

3. Da?l?, Ö., Tosun, F. and K?l?ç, A. (2020) Evaluation of Surgical Site Infections and Analysis of Risk Factors. ANKEM Journal, 34, 91-98.

4. Lin S, Melki S, Lisgaris MV, Ahazizadeh EN, Zender CA. Postoperative MRSA infections in head and neck surgery. Am J Otolaryngol. 2017;38(4):417–421

5. Fry DE. Fifty ways to cause surgical site infections. Surg Infect (Larchmt). 2011;12(6):497–500

6. Cullen KA, Hall MJ, Golosinskiy A. Ambulatory surgery in the United States. Natl Health Stat Report. 2009;(28):1–25.

7. Jenks PJ, Laurent M, McQuarry S, Watkins R. Clinical and economic burden of surgical site infection (SSI) and predicted financial consequences of elimination of SSI from an English hospital. J Hosp Infect. 2014;86(1):24-33.

8. Reichman DE, Greenberg JA. Reducing surgical site infections: a review. Rev Obstet Gynecol. 2009;2(4):212.

9. Parienti JJ, Thibon P, Heller R, Le Roux Y, von Theobald P, Bensadoun H, et al. Hand-rubbing with an aqueous alcoholic solution vs traditional surgical hand-scrubbing and 30-day surgical site infection rates: a randomized equivalence study. JAMA. 2002; 288(6):722-7.

10. Ateæ S, Nazik S, ?ahin AR, Karda? F, Erdo?an A. Evaluation of surgical site infections. J Kahramanmara? Sütçü Imam Univ Fac Med. 2019;14:16–19.

11. Marul F, Aygin D. Innovations in the definitions of surgical site infection and current practices in preoperative feather cleaning. Online Turk J Health Sci. 2016;1:28–36.

12. Korol E, Johnston K, Waser N, Sifakis F, Jafri HS, Lo M, et al. A systematic review of risk factors associated with surgical site infections among surgical patients. PLoS One. 2013;8(12):e83743.

13. Lin S, Melki S, Lisgaris MV, Ahadizadeh EN, Zender CA et al. Post-operative MRSA infections in head and neck surgery. Am J Otolaryngol. 2017;38(4):417-421.

14. Misha G, Chelkeba L, Melaku T. Incidence, risk factors and outcomes of surgical site infections among patients admitted to Jimma Medical Center, South West Ethiopia: Prospective cohort study. Ann Med Surg (Lond). 2021;65:102247.

15. Mohan N, Gnanasekar D, Tk S, Ignatious A. Prevalence and Risk Factors of Surgical Site Infections in a Teaching Medical College in the Trichy District of India. Cureus. 2023;15(5):e39465

16. Ademi A, Dika-Haxhirexha F, Dogjani A, Haxhirexha K. A Comprehensive Systematic Review of Etiology and Risk Factors of Surgical Site Infections. Albanian J Trauma Emerg Surg. 2025;9(1): 1650-1655.

17. Duran A, Gülay H, Terzi MC. Risk factors in surgical site infections. Surgical Sci, 2024;15:64-80.

18. Alfonso-Sanchez JL, Martinez IM, Martín-Moreno JM, González RS, Botía F. Analyzing the risk factors influencing surgical site infections: the site of environmental factors. Can J Surg. 2017;60(3):155-61

19. Yang J, Zhang X, Liang W. A retrospective analysis of factors affecting surgical site infection in orthopaedic patients. J Int Med Res. 2020;48(4):300060520907776.

20. Kaye KS, Schmit K, Pieper C, Sloane R, Caughlan KF, Sexton DJ, et al. The effect of increasing age on the risk of surgical site infection. J Infect Dis. 2005;191(7):1056-62.

21. Kaye KS, Schmader KE, Sawyer R. Surgical site infection in the elderly population. Clin Infect Dis. 2004; 39(12):1835-41.

22. Alkaaki A, Al-Radi OO, Khoja A, Alnawawi A, Alnawawi A, Maghrabi A, et al. Surgical site infection following abdominal surgery: a prospective cohort study. Can J Surg. 2019;62(2):111-117.

23. Guzmán-García C, Flores-Barrientos OI, Juárez-Rojop IE, Robledo-Pascual JC, Baños-González MA, Tovilla-Záratee CA, et al. Abdominal surgical site infection incidence and risk factors in a Mexican population. Adv Skin Wound Care. 2019; 32:1-6.

24. Langelotz C, Mueller-Rau C, Terziyski S, Rau B, Krannich A, Gastmeier P, et al. Gender-specific differences in surgical site infections: an analysis of 438,050 surgical procedures from the German national Nosocomial infections surveillance system. Viszeralmedizin. 2014;30(2):114-7.

25. Li H, Zheng X, Gao J. Extensive analysis of risk factors associated with surgical site infections post-cardiothoracic open surgery. Int Wound J. 2024;21(3):e14842.

26. Holl J, Kowalewski C, Zimek Z, Fiedor P, Kaminski A, Oldak T, et al. Chronic diabetic wounds and their treatment with skin substitutes. Cells. 2021;10(3):655.

27. Bashir H, Bhat SA, Majid S, Hamid R, Koul RK, Rehman MU, et al. Role of inflammatory mediators (TNF-a, IL-6, CRP), biochemical and hematological parameters in type 2 diabetes mellitus patients of Kashmir, India. Med J Islamic Repub Iran. 2020;34:5.

28. Guo S, Dipietro LA. Factors affecting wound healing. J Dent Res. 2010;89(3):219-29.

29. Langit MB, Miwa S, Yamamoto N, Hayashi K, Takeuchi A, Igarashi K, et al. Risk factors for postoperative deep infection after malignant bone tumor surgery of the extremities. Anticancer Res. 2020;40(6): 3551-3557.

30. Hardwicke JT, Bechar J, Skillman JM. Are systemic antibiotics indicated in aesthetic breast surgery? A systematic review of the literature. Plast Reconstr Surg. 2013;131(6):1395-1403

31. Li GH, Hou DJ, Fu HD, Guo JY, Guo XB, Gong H. A review of prophylactic antibiotics use in plastic surgery in China and a systematic review. Int J Surg. 2014; 12(12):1300-5.

32. Zhang Y, Dong J, Qiao Y, He J, Wang T, Ma S. Efficacy and safety profile of antibiotic prophylaxis usage in clean and clean-contaminated plastic and reconstructive surgery: a meta-analysis of randomized controlled trials. Ann Plast Surg. 2014;72(1):121-30;

33. Lalla SC, Bonadurer GF, Murad MH, Brewer JD. Prophylactic antibiotics and Postoperative Surgical Site Infections in cutaneous surgery: A systematic review and meta-analysis. Int J Surg Open. 2022; 47:100556.

34. Jatoliya H, Pipal RK, Pipal DK, Biswas P, Pipal VR, Yadav S, et al. Surgical site infections in elective and emergency abdominal surgeries: A prospective observational study about incidence, risk factors, pathogens, and antibiotic sensitivity at a Government Tertiary Care Teaching Hospital in India. Cureus. 2023;15(10): e48071.

35. Saad D, Alla M, Abdelzaher M. Surgical site infection after emergency and elective abdominal surgery: Incidence and risk factors. Zagazig Univ Med J. 2024; 30(1):211-217.

36. Rehman W, Ali Shah SI, Zulfiqar H, et al. Emergency vs elective abdominal surgery in terms of surgical site infection. J Pharmaceut Negative Results. 2022; 13(7):4009-4014

37. Megahed HA, Taki-Eldin A, Mohamed AA, El-Syed Ibrahim MK, Abdel Aziz AA, Megahed HA, et al. Risk factors for surgical site infections in elective and emergency surgeries: A prospective cohort study. Med J Islam Repub Iran. 2025;39:55.

38. Habteweld HA, Yimam M, Tsige AW, Teshome Wondmkun Y, Endalifer BL, Dires Ayenew K. Surgical site infection and antimicrobial prophylaxis prescribing profile, and its determinants among hospitalized patients in Northeast Ethiopia: a hospital based cross-sectional study. Sci Rep. 2023;13(1):14689.

39. Napolitano F, Tomassoni D, Cascone D, Di Giuseppe G; Collaborative Working Group. Evaluation of hospital readmissions for surgical site infections in Italy. Eur J Public Health. 2018; 28(3):421–425.

40. Shah R, Pavey E, Ju M, Merkow R, Rajaram R, Wandling MW, et al. Evaluation of readmissions due to surgical site infections: A potential target for quality improvement. Am J Surg. 2017; 214(5):773-779.



Full Text Sources: Download pdf
Abstract:   Abstract EN
Views: 64


Watch Video Articles


For Authors



Journal Subscriptions

Current Issue

Jun 2025

Supplements

Instructions for authors
Online submission
Contact
ISSN: 2559 - 723X (print)

e-ISSN: 2601 - 1700 (online)

ISSN-L: 2559 - 723X

Journal Abbreviation: Surg. Gastroenterol. Oncol.

Surgery, Gastroenterology and Oncology (SGO) is indexed in:
  • SCOPUS
  • EBSCO
  • DOI/Crossref
  • Google Scholar
  • SCImago
  • Harvard Library
  • Open Academic Journals Index (OAJI)

Open Access Statement

Surgery, Gastroenterology and Oncology (SGO) is an open-access, peer-reviewed online journal published by Celsius Publishing House. The journal allows readers to read, download, copy, distribute, print, search, or link to the full text of its articles.

Journal Metrics

Time to first editorial decision: 25 days
Rejection rate: 61%
CiteScore: 0.2



Meetings and Courses in 2025
Meetings and Courses in 2024
Meetings and Courses in 2023
Meetings and Courses in 2022
Meetings and Courses in 2021
Meetings and Courses in 2020
Meetings and Courses in 2019
Verona expert meeting 2019

Creative Commons License
Surgery, Gastroenterology and Oncology applies the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits readers to copy and redistribute the material in any medium or format, remix, adapt, build upon the published works non-commercially, and license the derivative works on different terms, provided the original material is properly cited and the use is non-commercial. Please see: https://creativecommons.org/licenses/by-nc/4.0/
Publisher’s Note:
The opinions, statements, and data contained in article are solely those of the authors and not of Surgery, Gastroenterology and Oncology journal or the editors. Publisher and the editors disclaim responsibility for any damage resulting from any ideas, instructions, methods, or products referred to in the content.